Low Doses of Calcium-Heparin in Liver Cirrhosis

• References

• 1 Bloom AL. Intravascular coagulation and the liver. Br J Haematol 1975; 30: 1-7
• 2 Cordova C, Musca A, Violi F, Alessandri C, Vezza E. Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin. Scan J Haematol 1982; 29: 235-240
• 3 Straub PW. Diffuse intravascular coagulation in liver disease?. Semin Thromb Haemostas 1977; 4: 29-39
• 4 Coccheri S, Mannucci PM, Palareti G, Gervasoni W, Poggi M, Viganò S. Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis. Br J Haematol 1982; 52: 503-509
• 5 Violi F, Alessandri C, Iuliano L, Frattaroli S, Gallina G, Balsano F. Behaviour of FDP, plasminogen, and alpha₂-antiplasmin in chronic active hepatitis and liver cirrhosis patients showing high FpA values. Haemostasis 1984; 1: 109
• 6 Violi F, Alessandri C, Iuliano L, Frattaroli S, Gallina G, Cordova C. Fibrinopeptide A plasma levels in liver cirrhotic patients. VIII International Congress on Thrombosis, Istanbul June 4–7. 1984 abstract n 299
• 7 Violi F, Alessandri C, Iuliano L, Frattaroli S, Balsano F. Blood coagulation consumption in a patient with autoimmune chronic active hepatitis. Haematologica 1984; 69: 449-451
• 8 Mattler LE, Bang NU. Serine protease specificity for peptide chromogenic substrates. Thromb Haemostas 1977; 38: 776-792